Testing version — LOERadar is in active testing. Features and data may change.

CARBIDOPA, LEVODOPA AND ENTACAPONE (CARBIDOPA; ENTACAPONE; LEVODOPA) | LOERadar

Viewing data from:

CARBIDOPA, LEVODOPA AND ENTACAPONE

ANDA

CARBIDOPA; ENTACAPONE; LEVODOPA | A090833 | WOCKHARDT LTD

5 strengths0 unique patents0 unique exclusivities

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Dec 18, 2012	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (5)

Sort:

#001 — 18.75MG;200MG;75MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Nov 20, 2012

No patent or exclusivity listings for this strength.

#002 — 25MG;200MG;100MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Nov 20, 2012

#003 — 31.25MG;200MG;125MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Nov 20, 2012

#004 — 37.5MG;200MG;150MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Nov 20, 2012

#005 — 50MG;200MG;200MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Nov 20, 2012